It surprises me quite as much as it must surely do you to find myself this evening wandering into the curtilage of the neurologist's domain, f?r few physicians are less well equipped than myself for such an exploration. My Table I ). One died four years after diagnosis. The other 7 have survived for periods of time varying from six to fifteen years from the onset of their first symptom. They are all at work and with the help of neostigmine not greatly handicapped. The dose of neostigmine has not on the whole increased very much since they were originally discharged from hospital and in 2 cases it has fallen. This is noteworthy when one takes into account the fact that we are now much less niggardly in its use than we were some years ago, particularly since the State has become responsible for its cost to all patients. I am not trying to make out a case for the benignity of myasthenia. With 
